Fact CheckerSign in

NCT02756091Recruiting

International Intracranial Dissection Study

International Intracranial Artery Dissection Study

Source: ClinicalTrials.gov · Last updated 13 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Cervicocerebral artery dissection is a major cause for stroke in young adults. While knowledge of cervical artery dissection (CeAD) has increased thanks to a number of high quality studies, knowledge on intracranial artery dissection (IAD) is limited. Due to treatment and publication bias little is known about the natural history of IAD. Overall, IAD is assumed to have a more severe course than CeAD, with a more ominous outcome in patients with subarachnoid hemorrhage (SAH). Furthermore, little information is available on the risk of recurrent IAD as well as on the risk of recurrent ischemic and haemorrhagic events in non-Asian patients. Radiological diagnosis of IAD can be challenging given the small size of intracranial arteries, and the subtle and non-specific radiological signs which tend to evolve over time. The optimal treatment of IAD is unknown. There are no randomised trials and only observational studies with relatively small sample sizes are available, thus providing a very low level of evidence. Finding the factors that are decisive for outcome and recurrence after intracranial artery dissection is key to an improved management of this potentially severe disease predominantly affecting young patients. By using standardised protocols for diagnosis, imaging and follow-up, the investigators intend to obtain large representative patient samples in order to fill the gap of evidence.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
11 Apr 2016
Start date
Aug 2016
Primary completion date
30 Nov 2026
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Diseases
Stroke
NCT number
NCT02756091

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From Aug 2016 to the primary completion date, 30 Nov 2026
  • 3 sites in 2 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Iatrogenic dissection caused by endovascular intervention
  • Extracranial dissection with intracranial extension

Who the study is looking for

  • Patients with acute Intracranial Artery Dissection (symptom onset ≤ 30 days)
  • Age ≥ 18 years
  • Consent to participate according to local requirements

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurology, University Hospital Basel
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting
Department of Neurology, Inselspital Bern
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting
National Cerebral and Cardiovascular Center Osaka
Coordinator of this site? Confirm its status
OsakaJapanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.